Distinct interactors define the p63 transcriptional signature in epithelial development or cancer. Issue 12 (30th June 2022)

• Record Type: Journal Article
• Authors: Pecorari, Rosalba; Bernassola, Francesca; Melino, Gerry; Candi, Eleonora
• Is Part Of: Biochemical journal. Volume 479:Issue 12(2022)
• Page Start: 1375
• Page End: 1392
• Publication Date: 2022-06-30
• Subjects: cancer -- epithelial cells -- keratinocytes -- p63; Biochemistry -- Periodicals; 572
• DOI: 10.1042/BCJ20210737
• Languages: English
• ISSNs: 0264-6021

Abstract

Abstract : The TP63 is an indispensable transcription factor for development and homeostasis of epithelia and its derived glandular tissue. It is also involved in female germline cell quality control, muscle and thymus development. It is expressed as multiple isoforms transcribed by two independent promoters, in addition to alternative splicing occurring at the mRNA 3′-UTR. Expression of the TP63 gene, specifically the amino-deleted p63 isoform, ΔNp63, is required to regulate numerous biological activities, including lineage specification, self-renewal capacity of epithelial stem cells, proliferation/expansion of basal keratinocytes, differentiation of stratified epithelia. In cancer, ΔNp63 is implicated in squamous cancers pathogenesis of different origin including skin, head and neck and lung and in sustaining self-renewal of cancer stem cells. How this transcription factor can control such a diverse set of biological pathways is central to the understanding of the molecular mechanisms through which p63 acquires oncogenic activity, profoundly changing its down-stream transcriptional signature. Here, we highlight how different proteins interacting with p63 allow it to regulate the transcription of several central genes. The interacting proteins include transcription factors/regulators, epigenetic modifiers, and post-transcriptional modifiers. Moreover, as p63 depends on its interactome, we discuss the hypothesis to target the protein interactors to directly affect p63 oncogenic activities and p63-related diseases.